Patterns of recurrence and survival after complete resection of pathological stage N2 small cell lung cancer

被引：0
|
作者：
Yu, L. [1 ]
Xu, J. [1 ]
Qiao, R. [1 ]
Zhong, H. [1 ]
Han, B. [1 ]
Zhong, R. [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Dept Pulm Med, Shanghai Chest Hosp, Shanghai, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
59P
引用
收藏
页码：S727 / S727
页数：1
相关论文
共 50 条
  • [31] Recurrence Dynamics for Pathological N2 Non-small Cell Lung Cancer depending on the IASLC Residual Tumor Descriptor
    Kim, I. H.
    Yun, J. K.
    Lee, G. D.
    Choi, S.
    Kim, H. R.
    Kim, Y. -H.
    Kim, D. K.
    Park, S. -I.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S293 - S294
  • [32] Long term survival after pulmonary resection for stage I small cell lung cancer
    DellaPona, C
    Massera, F
    Tondini, M
    Robustellini, M
    Rossi, G
    Rocco, G
    Vertemati, G
    Meroni, A
    Rizzi, A
    INTERNATIONAL CONGRESS OF THORAX SURGERY, 1997, : 325 - 329
  • [33] Recurrence Dynamics of Pathological N2 Non-Small Cell Lung Cancer Based on IASLC Residual Tumor Descriptor
    Kim, In Ha
    Lee, Geun Dong
    Choi, Sehoon
    Kim, Hyeong Ryul
    Kim, Yong-Hee
    Kim, Dong Kwan
    Park, Seung-Il
    Yun, Jae Kwang
    CANCER RESEARCH AND TREATMENT, 2025, 57 (01): : 105 - 115
  • [34] VALIDITY AND FEASIBILITY OF RE-RESECTION FOR THE SOLITARY LUNG RECURRENCE AFTER COMPLETE RESECTION IN NON-SMALL CELL LUNG CANCER
    Funaki, Soichiro
    Nakagiri, Tomoyuki
    Shintani, Yasushi
    Inoue, Masayoshi
    Sawabata, Noriyoshi
    Minami, Masato
    Okumura, Meinoshin
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S474 - S474
  • [35] EPIGENETIC INACTIVATION OF MDFI PREDICTS POOR RECURRENCE-FREE SURVIVAL AFTER COMPLETE RESECTION OF PATHOLOGIC STAGE I NON-SMALL CELL LUNG CANCER
    Harada, Hiroaki
    Miyamoto, Kazuaki
    Yamashita, Yoshinori
    Tsubokawa, Norifumi
    Okada, Morihito
    RESPIROLOGY, 2015, 20 : 88 - 88
  • [36] Adjuvant radiation therapy improves survival in stage IIIA (N2) non-small cell lung cancer with persistent N2 disease after neoadjuvant chemotherapy
    Komiya, Takefumi
    Takamori, Shinkichi
    Wilding, Gregory
    RADIOTHERAPY AND ONCOLOGY, 2022, 176 : 234 - 238
  • [37] Prognostic factors for post-recurrence survival in patients with completely resected Stage III (N2) non-small-cell lung cancer
    Cho, Sukki
    Yum, Sungwon
    Kim, Kwhanmien
    Jheon, Sanghoon
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2018, 54 (03) : 554 - 559
  • [38] ROLE OF POSTOPERATIVE RADIOTHERAPY AFTER CURATIVE RESECTION AND ADJUVANT CHEMOTHERAPY FOR PATIENTS WITH PATHOLOGICAL STAGE N2 NON-SMALL CELL LUNG CANCER: A PROPENSITY SCORE MATCHING ANALYSIS
    Kim, Hak Jae
    Kim, Byoung Hyuck
    Wu, Hong-Gyun
    Kang, Chang Hyun
    Kim, Young Tae
    Lee, Se-Hoon
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S856 - S856
  • [39] Role of Postoperative Radiotherapy After Curative Resection and Adjuvant Chemotherapy for Patients With Pathological Stage N2 Non-Small-Cell Lung Cancer: A Propensity Score Matching Analysis
    Kim, Byoung Hyuck
    Kim, Hak Jae
    Wu, Hong-Gyun
    Kang, Chang Hyun
    Kim, Young Tae
    Lee, Se-Hoon
    Kim, Dong-Wan
    CLINICAL LUNG CANCER, 2014, 15 (05) : 356 - 364
  • [40] Residual N2 or N3 disease after induction chemoradiation in stage III non small cell lung cancer predicts for distant recurrence
    DeYoung, C. M.
    Edelman, M.
    Buchner, E.
    Kwong, K.
    Gamliel, Z.
    Krasna, M.
    Schuetz, J.
    Suntharalingam, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S461 - S462
12345